Form 4: ARS Pharmaceuticals Executive Exercises Stock Options, Boosting Indirect Ownership
SEC Form 4
Sarina Tanimoto, Chief Medical Officer of ARS Pharmaceuticals, reports exercising stock options, increasing her indirect beneficial ownership through spousal and trust holdings.
Summary
- Sarina Tanimoto, the Chief Medical Officer of ARS Pharmaceuticals, filed a Form 4 detailing changes in her beneficial ownership of the company's stock.
- On April 19, 2024, Tanimoto exercised stock options to acquire 119,047 shares at $0.84 and 69,444 shares at $1.44.
- These transactions increased her indirect ownership through her spouse's holdings.
- Tanimoto also has indirect ownership through the Richard Lowenthal Charitable Remainder UniTrust, the Lowenthal-Tanimoto Family Trust, and the Sarina Tanimoto Charitable Remainder UniTrust.
- Following the reported transactions, Tanimoto's total direct holdings amount to 3,276,854 shares.
- Her indirect holdings include 4,315,313 shares held by her spouse, 1,646,494 shares held by the Richard Lowenthal Charitable Remainder UniTrust, 1,848,499 shares held by the Lowenthal-Tanimoto Family Trust, and 1,647,447 shares held by the Sarina Tanimoto Charitable Remainder UniTrust.
Sentiment
Score: 5
Explanation: Neutral sentiment as it is a routine disclosure of stock option exercises.
Positives
- Executive's exercise of stock options may signal confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential sentiment.
Comparison to Industry Standards
- Executive compensation packages often include stock options to align management's interests with those of shareholders.
- The vesting schedules and exercise prices are typical for stock option grants.
- Comparing the size of Tanimoto's holdings and option exercises to those of executives at comparable pharmaceutical companies would provide further context.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
- The exercise of stock options could have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 01/07/2020 | Date of Richard Lowenthal Charitable Remainder UniTrust and Sarina Tanimoto Charitable Remainder UniTrust |
| 04/03/2006 | Date of Lowenthal-Tanimoto Family Trust |
| 04/19/2024 | Date of stock option exercise |
| 04/22/2024 | Date of Form 4 filing |
| 12/16/2029 | Expiration date of some stock options |
| 12/13/2031 | Expiration date of some stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.